0001213900-24-043536.txt : 20240515 0001213900-24-043536.hdr.sgml : 20240515 20240515154754 ACCESSION NUMBER: 0001213900-24-043536 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amplify ETF Trust CENTRAL INDEX KEY: 0001633061 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-37731 FILM NUMBER: 24949892 BUSINESS ADDRESS: STREET 1: 310 S. HALE ST. CITY: WHEATON STATE: IL ZIP: 60187 BUSINESS PHONE: (630)869-0202 MAIL ADDRESS: STREET 1: 310 S. HALE ST. CITY: WHEATON STATE: IL ZIP: 60187 8-A12B 1 ea0206192-01_8a12b.htm 8-A12B

Securities and Exchange Commission

Washington, D.C.

Form 8-A

For Registration of Certain Classes of Securities

Pursuant to Section 12(b) or (g) of the

Securities Exchange Act of 1934

Amplify ETF Trust
(Exact name of registrant as specified in its charter)

Massachusetts	See Exhibit 1
(State of Incorporation or Organization)	(I.R.S. Employer Identification No.)

3333 Warrenville Rd, Suite 350 Lisle, Illinois	60532
(Address of Principal Executive Offices)	(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class to be so registered	Name of each exchange on which each class is to be registered

Common Shares of Beneficial Interest, $0.01 par value per share, of Amplify Weight Loss Drug & Treatment ETF	NYSE Arca, Inc.

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A. (c), check the following box. ☒

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A. (d), check the following box. ☐

Securities Act registration statement file number to which this form relates: 333-207937

Securities to be registered pursuant to Section 12(g) of the Act:

None

Title of Each Class to be Registered

Information Required in Registration Statement

Item 1.

Description of Registrant’s Securities to be Registered

The securities to be registered hereunder are common shares of beneficial interest, $0.01 par value per share (the “Shares”), of the Amplify Weight Loss Drug & Treatment ETF (the “Fund”), a series of the Amplify ETF Trust (the “Registrant”). An application for listing of the Shares of the Fund has been filed with and approved by NYSE Arca, Inc. A description of the Shares is contained in the Preliminary Prospectus, which is a part of Post-Effective Amendment No. 331 to the Registration Statement on Form N-1A (Registration Nos. 333-207937 and 811-23108), filed with the Securities and Exchange Commission on March 6, 2024. Such description is incorporated by reference herein.

Item 2.

Exhibits

1. Registrant’s Amended and Restated Declaration of Trust and Establishment and Designation of Series Attached Thereto as Schedule A, incorporated herein by reference to Exhibit (a)(2) to the Registrant’s Pre-Effective Amendment No. 1 to the registration statement on Form N-1A filed December 23, 2015 (File Nos. 333-207937; 811-23108).

2. By-Laws of the Registrant, incorporated herein by reference to Exhibit (b) to the Registrant’s Pre-Effective Amendment No. 1 to the registration statement on Form N-1A filed December 23, 2015 (File Nos. 333-207937; 811-23108).

Signature

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

	Amplify ETF Trust

	By:	/s/ Christian Magoon
		Christian Magoon
		Chief Executive Officer and President

May 15, 2024

Exhibit 1

Fund	I.R.S. Employer Identification No.
Amplify Weight Loss Drug & Treatment ETF	99-2058149